BrightGene Bio-Medical Technology Co Ltd Sustainability Reports
BrightGene Bio-Medical Technology Co., Ltd. operates as a research-driven biopharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms across therapeutic fields such as antiviral, antifungal, and oncology treatments.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00FFDW3F3
1 reports from 2024 to 2024
